• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2017, Vol. 19 ›› Issue (1): 79-82.DOI: 10.3969/j.issn.1671-2587.2017.01.022

Previous Articles     Next Articles

The Application Value of Acute Leukemia Minimal Residual Disease with Bone Marrow Biopsy Detecting

XU Rui-qin, HU Ke-ni   

  1. Heze City of Shandong Province Hospital of Traditional Chinese Medicine Haematology Department Shandong Heze 274000
  • Received:2016-08-05 Online:2017-02-20 Published:2017-03-02

Abstract: Objective To investigate application value of bone marrow biopsy detection of acute leukemia minimal residual disease. Method s78 cases of adult acute leukemia patients in our hospital during the period January 2013 - January 2014 were treated as the research object,using bone marrow biopsy after chemotherapy,12,24 ,36 and 48 months in patients with bone marrow smear and biopsy of implementation,comparison of bone marrow cytology and bone marrow biopsy Results,statistical processing. Results A total of 78 patients with bone marrow biopsy were performed 290 times in this group. The positive aspects of minimal residual lesions were 12 months and 24 months,36 months and 48 months,and the difference was significant (P<0.05).In minimal residual lesions and recurrence: there were minimal residual lesions in 12 and 24 months,and 2 patients relapsed after chemotherapy,there were no minimal residual lesions in 1 cases,and 1 patients with minimal residual disease. Minimal residual lesions were positive in the continuous remission group. Conclusion Bone marrow biopsy is safe and convenient,and it has a certain reference value for the detection of minimal residual disease in adult patients with acute myeloid leukemia.

Key words: Adult acute leukemia, Minimal residual disease, Bone marrow biopsy

CLC Number: